Følg
Minesh Mehta
Minesh Mehta
Miami Cancer Institute
Verifisert e-postadresse på fiu.edu
Tittel
Sitert av
Sitert av
År
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
DW Andrews, CB Scott, PW Sperduto, AE Flanders, LE Gaspar, ...
The Lancet 363 (9422), 1665-1672, 2004
27402004
A randomized trial of bevacizumab for newly diagnosed glioblastoma
MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ...
New England Journal of Medicine 370 (8), 699-708, 2014
25922014
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
PW Sperduto, N Kased, D Roberge, Z Xu, R Shanley, X Luo, PK Sneed, ...
Journal of Clinical Oncology 30 (4), 419, 2012
12962012
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402
G Cairncross, M Wang, E Shaw, R Jenkins, D Brachman, J Buckner, ...
Journal of clinical oncology 31 (3), 337, 2013
11082013
A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database
PW Sperduto, B Berkey, LE Gaspar, M Mehta, W Curran
International Journal of Radiation Oncology* Biology* Physics 70 (2), 510-514, 2008
10452008
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients
PW Sperduto, ST Chao, PK Sneed, X Luo, J Suh, D Roberge, A Bhatt, ...
International Journal of Radiation Oncology* Biology* Physics 77 (3), 655-661, 2010
10012010
Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II …
V Gondi, SL Pugh, WA Tome, C Caine, B Corn, A Kanner, H Rowley, ...
Journal of Clinical Oncology 32 (34), 3810, 2014
9542014
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
ME Hegi, L Liu, JG Herman, R Stupp, W Wick, M Weller, MP Mehta, ...
Journal of clinical oncology 26 (25), 4189-4199, 2008
9392008
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial
MR Gilbert, M Wang, KD Aldape, R Stupp, ME Hegi, KA Jaeckle, ...
Journal of clinical oncology 31 (32), 4085, 2013
8972013
Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma
JC Buckner, EG Shaw, SL Pugh, A Chakravarti, MR Gilbert, GR Barger, ...
New England Journal of Medicine 374 (14), 1344-1355, 2016
8482016
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group …
G Cairncross, B Berkey, E Shaw, R Jenkins, B Scheithauer, D Brachman, ...
J Clin Oncol 24 (18), 2707-2714, 2006
8372006
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
PD Brown, S Pugh, NN Laack, JS Wefel, D Khuntia, C Meyers, A Choucair, ...
Neuro-oncology 15 (10), 1429-1437, 2013
7762013
A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis
RM Auchter, JP Lamond, E Alexander III, JM Buatti, R Chappell, ...
International Journal of Radiation Oncology* Biology* Physics 35 (1), 27-35, 1996
6761996
Image guidance for precise conformal radiotherapy
TR Mackie, J Kapatoes, K Ruchala, W Lu, C Wu, G Olivera, L Forrest, ...
International Journal of Radiation Oncology* Biology* Physics 56 (1), 89-105, 2003
6542003
Response assessment criteria for brain metastases: proposal from the RANO group
NU Lin, EQ Lee, H Aoyama, IJ Barani, DP Barboriak, BG Baumert, ...
The lancet oncology 16 (6), e270-e278, 2015
6382015
Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial
CA Meyers, JA Smith, A Bezjak, MP Mehta, J Liebmann, T Illidge, ...
Journal of clinical oncology 22 (1), 157-165, 2004
6222004
Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with …
L Souhami, W Seiferheld, D Brachman, EB Podgorsak, M Werner-Wasik, ...
International Journal of Radiation Oncology* Biology* Physics 60 (3), 853-860, 2004
6202004
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases
PK Sneed, JH Suh, SJ Goetsch, SN Sanghavi, R Chappell, JM Buatti, ...
International Journal of Radiation Oncology* Biology* Physics 53 (3), 519-526, 2002
5992002
The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
ME Linskey, DW Andrews, AL Asher, SH Burri, D Kondziolka, ...
Journal of neuro-oncology 96, 45-68, 2010
5792010
Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model
LE Abrey, L Ben-Porat, KS Panageas, J Yahalom, B Berkey, W Curran, ...
Journal of Clinical Oncology 24 (36), 5711-5715, 2006
5652006
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20